Clinical analysis of four Chinese hemophiliacs with human immunodeficiency virus infection.
Human immunodeficiency virus (HIV) is now considered as the causative agent of acquired immunodeficiency syndrome (AIDS). A high risk of AIDS has been reported among patients with hemophilia who received lyophilized commercial factor VIII and IX concentrates of American origin. At a prevalent survey from September to December 1985, HIV antibodies were found in all four patients with hemophilia treated with the batch number W87307, 955 I.U. of American commercial factor VIII concentrate supplied by Armour Pharmaceutical Company, USA. One of the sero-positive patients developed AIDS-related complex (ARC) and died of cerebral hemorrhage. The other three sero-positive patients had abnormalities in cell-mediated immunity. Of them two developed left lumbosacral radiculopathy and hemorrhagic herpes zoster and one remained well so far.
Tang
D J
DJ
Xu
Y H
YH
Dai
D
D
Han
Y J
YJ
Wang
B C
BC
Lang
Y M
YM
Liang
Y
Y
Zeng
Y
Y
D000386:AIDS-Related Complex / Q000209:etiology* / Q000473:pathology; D000293:Adolescent; D000328:Adult; D002648:Child; D005169:Factor VIII / Q000009:adverse effects*; D006679:HIV Seropositivity; D006467:Hemophilia A / Q000628:therapy*; D006801:Humans
D005169:Factor VIII